SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Gevo, Inc. – ‘10-K’ for 12/31/19 – ‘EX-4.13’

On:  Tuesday, 3/17/20, at 5:31pm ET   ·   For:  12/31/19   ·   Accession #:  1437749-20-5495   ·   File #:  1-35073

Previous ‘10-K’:  ‘10-K’ on 3/28/19 for 12/31/18   ·   Next:  ‘10-K’ on 3/18/21 for 12/31/20   ·   Latest:  ‘10-K’ on 3/7/24 for 12/31/23   ·   10 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/17/20  Gevo, Inc.                        10-K       12/31/19   84:7.8M                                   RDG Filings/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.06M 
 2: EX-4.13     Instrument Defining the Rights of Security Holders  HTML     40K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     25K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     31K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     31K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
83: R1          Document And Entity Information                     HTML     65K 
34: R2          Consolidated Balance Sheets                         HTML    100K 
25: R3          Consolidated Balance Sheets (Parentheticals)        HTML     33K 
55: R4          Consolidated Statements of Operations               HTML     80K 
84: R5          Consolidated Statements of Stockholders' Equity     HTML     65K 
35: R6          Consolidated Statements of Cash Flows               HTML    118K 
26: R7          Note 1 - Nature of Business and Financial           HTML     47K 
                Condition                                                        
56: R8          Note 2 - Summary of Significant Accounting          HTML     88K 
                Policies                                                         
82: R9          Note 3 - Revenues From Contracts With Customers     HTML     85K 
                and Other Revenues                                               
31: R10         Note 4 - Leases, Right-to-Use Assets and Related    HTML     54K 
                Liabilities                                                      
23: R11         Note 5 - Inventories                                HTML     46K 
47: R12         Note 6 - Property, Plant and Equipment              HTML     70K 
73: R13         Note 7 - Embedded Derivatives                       HTML     53K 
32: R14         Note 8 - Accounts Payable and Accrued Liabilities   HTML     38K 
24: R15         Note 9 - Debt                                       HTML    127K 
48: R16         Note 10 - Equity Incentive Plans                    HTML     36K 
74: R17         Note 11 - Stock-based Compensation                  HTML    115K 
33: R18         Note 12 - Income Taxes                              HTML     62K 
22: R19         Note 13 - Employee Benefit Plan                     HTML     29K 
63: R20         Note 14 - Commitments and Contingencies             HTML     34K 
70: R21         Note 15 - Fair Value Measurements and Fair Value    HTML     92K 
                of Financial Instruments                                         
44: R22         Note 16 - Segments                                  HTML     79K 
18: R23         Significant Accounting Policies (Policies)          HTML    189K 
64: R24         Note 2 - Summary of Significant Accounting          HTML     43K 
                Policies (Tables)                                                
71: R25         Note 3 - Revenues From Contracts With Customers     HTML     71K 
                and Other Revenues (Tables)                                      
46: R26         Note 4 - Leases, Right-to-Use Assets and Related    HTML     45K 
                Liabilities (Tables)                                             
19: R27         Note 5 - Inventories (Tables)                       HTML     47K 
62: R28         Note 6 - Property, Plant and Equipment (Tables)     HTML     71K 
72: R29         Note 7 - Embedded Derivatives (Tables)              HTML     40K 
78: R30         Note 8 - Accounts Payable and Accrued Liabilities   HTML     37K 
                (Tables)                                                         
50: R31         Note 9 - Debt (Tables)                              HTML     96K 
21: R32         Note 11 - Stock-based Compensation (Tables)         HTML    109K 
30: R33         Note 12 - Income Taxes (Tables)                     HTML     56K 
76: R34         Note 15 - Fair Value Measurements and Fair Value    HTML     82K 
                of Financial Instruments (Tables)                                
49: R35         Note 16 - Segments (Tables)                         HTML     75K 
20: R36         Note 1 - Nature of Business and Financial           HTML     58K 
                Condition (Details Textual)                                      
29: R37         Note 2 - Summary of Significant Accounting          HTML     66K 
                Policies (Details Textual)                                       
75: R38         Note 2 - Summary of Significant Accounting          HTML     32K 
                Policies - Warrants (Details)                                    
51: R39         Note 2 - Summary of Significant Accounting          HTML     39K 
                Policies - Securities Potentially Dilute                         
                Calculation of Diluted Earnings Per Share                        
                (Details)                                                        
67: R40         Note 3 - Revenues From Contracts With Customers     HTML     42K 
                and Other Revenues (Details Textual)                             
58: R41         Note 3 - Revenues from Contracts with Customers     HTML     44K 
                and Other Revenues - Disaggregated Revenues                      
                (Details)                                                        
17: R42         Note 4 - Leases, Right-to-Use Assets and Related    HTML     46K 
                Liabilities (Details Textual)                                    
43: R43         Note 4 - Leases, Right-to-Use Assets and Related    HTML     44K 
                Liabilities - Lease Costs (Details)                              
66: R44         Note 4 - Leases, Right-to-Use Assets and Related    HTML     38K 
                Liabilities - Future Minimum Payments Under                      
                Non-cancelable Operating Leases (Details)                        
57: R45         Note 5 - Inventories - Components of Inventory      HTML     49K 
                Balances (Details)                                               
16: R46         Note 6 - Property, Plant and Equipment - Property,  HTML     59K 
                Plant and Equipment by Classification (Details)                  
42: R47         Note 6 - Property, Plant and Equipment -            HTML     30K 
                Depreciation and Amortization Expense (Details)                  
65: R48         Note 7 - Embedded Derivatives (Details Textual)     HTML     43K 
59: R49         Note 7 - Embedded Derivatives - Schedule of Inputs  HTML     38K 
                to Lattice Model Used to Value Embedded                          
                Derivatives (Details)                                            
53: R50         Note 8 - Accounts Payable and Accrued Liabilities   HTML     38K 
                - Components Accounts Payable and Accrued                        
                Liabilities in Consolidated Balance Sheets                       
                (Details)                                                        
79: R51         Note 9 - Debt (Details Textual)                     HTML     99K 
37: R52         Note 9 - Debt - Information Pertaining to           HTML     69K 
                Convertible Notes (Details)                                      
27: R53         Note 9 - Debt - Notes Payable - Other (Details)     HTML     37K 
54: R54         Note 9 - Debt - Future Payments for Notes Payable   HTML     42K 
                - Other (Details)                                                
80: R55         Note 10 - Equity Incentive Plans (Details Textual)  HTML     55K 
38: R56         Note 11 - Stock-based Compensation (Details         HTML     60K 
                Textual)                                                         
28: R57         Note 11 - Stock-based Compensation - Stock-Based    HTML     37K 
                Compensation Expense (Details)                                   
52: R58         Note 11 - Stock-based Compensation - Stock Option   HTML     65K 
                Award Activity (Details)                                         
81: R59         Note 11 - Stock-based Compensation - Non-Vested     HTML     47K 
                Restricted Stock (Details)                                       
39: R60         Note 11 - Stock-based Compensation - Determining    HTML     39K 
                Fair Value of Share-Based Payment Awards (Details)               
14: R61         Note 12 - Income Taxes (Details Textual)            HTML     36K 
60: R62         Note 12 - Income Taxes - Net Deferred Tax Assets    HTML     44K 
                (Details)                                                        
68: R63         Note 12 - Income Taxes - Reconciling Items from     HTML     43K 
                Income Tax Computed at the Statutory Federal Rate                
                (Details)                                                        
40: R64         Note 14 - Commitments and Contingencies (Details    HTML     30K 
                Textual)                                                         
15: R65         Note 15 - Fair Value Measurements and Fair Value    HTML     29K 
                of Financial Instruments (Details Textual)                       
61: R66         Note 15 - Fair Value Measurements and Fair Value    HTML     51K 
                of Financial Instruments - Schedule of Carrying                  
                Value and Fair Value by Fair Value Hierarchy of                  
                Financial Instruments (Details)                                  
69: R67         Note 15 - Fair Value Measurements and Fair Value    HTML     36K 
                of Financial Instruments - Schedule of Fair Value                
                Measurements Using Level 3 Inputs (Details)                      
41: R68         Note 16 - Segments (Details Textual)                HTML     27K 
13: R69         Note 16 - Segments - Information on Business        HTML     55K 
                Segments (Details)                                               
45: XML         IDEA XML File -- Filing Summary                      XML    158K 
77: EXCEL       IDEA Workbook of Financial Reports                  XLSX     71K 
 7: EX-101.INS  XBRL Instance -- gevo-20191231                       XML   2.13M 
 9: EX-101.CAL  XBRL Calculations -- gevo-20191231_cal               XML    135K 
10: EX-101.DEF  XBRL Definitions -- gevo-20191231_def                XML   1.33M 
11: EX-101.LAB  XBRL Labels -- gevo-20191231_lab                     XML   1.13M 
12: EX-101.PRE  XBRL Presentations -- gevo-20191231_pre              XML   1.37M 
 8: EX-101.SCH  XBRL Schema -- gevo-20191231                         XSD    220K 
36: ZIP         XBRL Zipped Folder -- 0001437749-20-005495-xbrl      Zip    187K 


‘EX-4.13’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  <>  <> 

Exhibit 4.13

 

DESCRIPTION OF SECURITIES

 

The following summary of the terms of the capital stock of Gevo, Inc. (“we,” “our” or “us”) is based upon our amended and restated certificate of incorporation and our amended and restated bylaws. The summary is not complete and is qualified by reference to our amended and restated certificate of incorporation and our amended and restated bylaws, each of which is filed as an exhibit to this Annual Report on Form 10-K and incorporated by reference herein. We encourage you to read our amended and restated certificate of incorporation, our amended and restated bylaws and the applicable provisions of the Delaware General Corporation Law (the “DGCL”) for additional information.

 

Authorized and Outstanding Capital Stock

 

Our authorized capital stock consists of 250,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share, issuable in one or more series designated by our board of directors.

 

Common Stock

 

The holders of our common stock have one vote per share. Holders of common stock are not entitled to vote cumulatively for the election of directors. Generally, all matters to be voted on by stockholders must be approved by a majority, or, in the case of election of directors, by a plurality, of the votes cast at a meeting at which a quorum is present, voting together as a single class, subject to any voting rights granted to holders of any then outstanding preferred stock. Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to participate equally in dividends when and as dividends may be declared by our board of directors out of funds legally available for the payment of dividends. In the event of our voluntary or involuntary liquidation, dissolution or winding up, the prior rights of our creditors and the liquidation preference of any preferred stock then outstanding must first be satisfied. The holders of common stock will be entitled to share in the remaining assets on a pro rata basis. No shares of common stock are subject to redemption or have redemptive rights to purchase additional shares of common stock.

 

Our common stock is listed on the Nasdaq Capital Market under the symbol “GEVO.”

 

Preferred Stock

 

Our amended and restated certificate of incorporation provides that we may issue shares of preferred stock from time to time in one or more series. Our board of directors is authorized to fix the voting rights, if any, designations, powers, preferences, qualifications, limitations and restrictions thereof, applicable to the shares of each series of preferred stock. Our board of directors may, without stockholder approval, issue preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of our common stock, including the likelihood that such holders will receive dividend payments and payments upon liquidation, and could have anti-takeover effects, including preferred stock or rights to acquire preferred stock in connection with implementing a stockholder rights plan. The ability of our board of directors to issue preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control or the removal of our existing management. There are currently no shares of preferred stock outstanding.

 

Anti-Takeover Provisions

 

The DGCL, our amended and restated certificate of incorporation, and our amended and restated bylaws contain provisions that could discourage or make more difficult a change in control of us, including an acquisition of us by means of a tender offer, a proxy contest and removal of our incumbent officers and directors, without the support of our board of directors. A summary of these provisions follows.

 

Statutory Business Combination Provision

 

We are subject to Section 203 of the DGCL, which, subject to certain exceptions, prohibits a Delaware corporation from engaging in any “business combination” with an “interested stockholder” for a period of three years following the time that such stockholder became an interested stockholder, unless:

 

 

the board of directors of the corporation approves either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder, prior to the time the interested stockholder attained that status;

 

 

upon the closing of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding, for purposes of determining the number of shares outstanding, those shares owned by persons who are directors and also officers and by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

 

 

at or subsequent to such time, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66-2/3% of the outstanding voting stock that is not owned by the interested stockholder.

 

With certain exceptions, an “interested stockholder” is a person or group who or which owns 15% or more of the corporation’s outstanding voting stock (including any rights to acquire stock pursuant to an option, warrant, agreement, arrangement or understanding, or upon the exercise of conversion or exchange rights, and stock with respect to which the person has voting rights only), or is an affiliate or associate of the corporation and was the owner of 15% or more of such voting stock at any time within the previous three years.

 

In general, Section 203 defines a business combination to include:

 

 

any merger or consolidation involving the corporation and the interested stockholder;

 

 

any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;

 

 

subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;

 

 

any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or

 

 

the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

 

A Delaware corporation may “opt out” of this provision with an express provision in its original certificate of incorporation or an express provision in its amended and restated certificate of incorporation or bylaws resulting from a stockholders’ amendment approved by at least a majority of the outstanding voting shares. However, we have not “opted out” of this provision. Section 203 could prohibit or delay mergers or other takeover or change-in-control attempts and, accordingly, may discourage attempts to acquire us.

 

Election and Removal of Directors

 

Our amended and restated certificate of incorporation provides for our board of directors to be divided into three classes, with staggered three-year terms. Only one class of directors is elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the shares of common stock outstanding are able to elect all of our directors. Directors may be removed only with cause by the affirmative vote of the holders of at least a majority of the outstanding shares entitled to vote on such removal.

 

No Stockholder Action by Written Consent

 

Our amended and restated certificate of incorporation and our amended and restated bylaws provide that any action required or permitted to be taken by the holders of common stock at an annual or special meeting of stockholders must be effected at a duly called meeting and may not be taken or effected by written consent of the stockholders.

 

Stockholder Meetings

 

Under our amended and restated certificate of incorporation and our amended and restated bylaws, only our board of directors, acting pursuant to a resolution adopted by a majority of the directors then in office, may call a special meeting of the stockholders, and any business conducted at any special meeting will be limited to the purpose or purposes specified in the notice for such special meeting.

 

Requirements for Advance Notification of Stockholder Nominations and Proposals

 

In order for our stockholders to bring nominations or business before an annual meeting properly, they must comply with certain notice requirements as provided by our amended and restated bylaws. Typically, in order for such notices to be timely, they must be provided to us not earlier than the close of business on the 120th day prior to the one-year anniversary of the preceding year’s annual meeting and not later than the close of business on the 90th day prior to the one-year anniversary of the preceding year’s annual meeting. For such notices to be timely in the event the annual meeting is advanced more than 30 days prior to or delayed by more than 70 days after the one-year anniversary of the preceding year’s annual meeting, notice must be provided to us not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting or, if later, the 10th day following the day on which public announcement of the date of such meeting is first made.

 

Amendment of Charter Provisions

 

The affirmative vote of the holders of at least 66-2/3% of the voting power of all of the then-outstanding shares of our voting stock, voting together as a single class, is required to, among other things, alter, amend or repeal certain provisions of our amended and restated certificate of incorporation, including those related to the classification of our board of directors, the amendment of our bylaws and certificate of incorporation, restrictions against stockholder actions by written consent, the designated parties entitled to call a special meeting of the stockholders and the indemnification of officers and directors.

 

Our amended and restated bylaws may only be amended (or new bylaws adopted) by our board of directors or the affirmative vote of the holders of at least 66-2/3% of the voting power of all of the then-outstanding shares of our voting stock.

 

Transfer Agent and Registrar

 

The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company. Its address is 6201 15th Avenue, Brooklyn, New York 11219 and its telephone number is (718) 921-8300.

 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/17/208-K
For Period end:12/31/19
 List all Filings 


10 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/06/22  Gevo, Inc.                        424B5                  2:484K                                   RDG Filings/FA
 2/24/22  Gevo, Inc.                        10-K       12/31/21  118:12M                                    RDG Filings/FA
 9/09/21  Gevo, Inc.                        424B5                  1:372K                                   RDG Filings/FA
 7/16/21  Gevo, Inc.                        S-8         7/16/21    3:90K                                    RDG Filings/FA
 5/14/21  Gevo, Inc.                        10-Q        3/31/21   76:5.7M                                   RDG Filings/FA
 3/18/21  Gevo, Inc.                        10-K       12/31/20   89:9.1M                                   RDG Filings/FA
 1/21/21  Gevo, Inc.                        424B5                  1:575K                                   RDG Filings/FA
 1/19/21  Gevo, Inc.                        S-3ASR      1/19/21    3:326K                                   RDG Filings/FA
12/30/20  Gevo, Inc.                        424B5                  1:550K                                   RDG Filings/FA
 8/24/20  Gevo, Inc.                        424B5                  1:707K                                   RDG Filings/FA
Top
Filing Submission 0001437749-20-005495   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 7:55:32.2pm ET